Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen

NCT00561470 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1226

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms
Neoplasm Metastasis

Interventions

DRUG: Placebo
DRUG: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
DRUG: FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)
DRUG: FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)

Sponsor

Sanofi

Collaborators

[object Object]
[object Object]